Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz

May 19, 2023
Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared HolzBlocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho healthcare sector strategist, joins ‘Fast Money’ to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.

Latest Mizuho News

Mizuho Americas wins five FCS Portfolio Awards

Mizuho Americas wins five FCS Portfolio Awards

May 20, 2026
Mizuho Head of Investment: AI is imacting every sector in the global economy

Mizuho Head of Investment: AI is imacting every sector in the global economy

June 9, 2026
Graig Suvannavejh: ASCO is one of the highlights of our year in biotech

Graig Suvannavejh: ASCO is one of the highlights of our year in biotech

May 29, 2026

Mizuho news from around the globe

back-to-top-blue